<DOC>
	<DOCNO>NCT00855101</DOCNO>
	<brief_summary>This study assess plasma concentration-time profile voriconazole adult receive 7-day intravenous treatment 6.5-day oral treatment . This study also assess safety profile voriconazole treatment period .</brief_summary>
	<brief_title>A Pharmacokinetic And Safety Study Of Voriconazole In Healthy Male And Female Adults</brief_title>
	<detailed_description />
	<mesh_term>Voriconazole</mesh_term>
	<criteria>Healthy male female subject 18 55 year old . Body weight 40 kg ( 88 lb ) 100 kg ( 220 lb ) . Subjects evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , ocular , neurologic , allergic disease . Subjects condition possibly affect drug absorption , eg , gastrectomy . Use prescription nonprescription drug dietary supplement within 7 day 5 halflives ( whichever longer ) prior first dose study medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Pharmacokinetics safety voriconazole intravenous oral adult</keyword>
</DOC>